Rationale for the use of high dose rFVIIa in a high-titre inhibitor patient with haemophilia B during major orthopaedic procedures.
This is a case report of a child with severe hemophilia B and high titer factor IX inhibitor who was not achieving good hemostasis on conventional doses of rFVIIa. Pharmacokinetic […]
Recombinant activated factor VII for adjunctive hemorrhage control in trauma – Discussion.
Comments were given by the authors on the paper by Martinowitz et al., mentioning that the study was not case controlled, the dose regimen was variable, how can thrombotic complications […]